Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3646762?pdf=render |
id |
doaj-ae8eb97003e4482a9245af5ef24533e7 |
---|---|
record_format |
Article |
spelling |
doaj-ae8eb97003e4482a9245af5ef24533e72020-11-25T01:44:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6307410.1371/journal.pone.0063074Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).Ruozhen HuJared WallaceTimothy J DahlemDavid Jonah GrunwaldRyan M O'ConnellMicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.http://europepmc.org/articles/PMC3646762?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ruozhen Hu Jared Wallace Timothy J Dahlem David Jonah Grunwald Ryan M O'Connell |
spellingShingle |
Ruozhen Hu Jared Wallace Timothy J Dahlem David Jonah Grunwald Ryan M O'Connell Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). PLoS ONE |
author_facet |
Ruozhen Hu Jared Wallace Timothy J Dahlem David Jonah Grunwald Ryan M O'Connell |
author_sort |
Ruozhen Hu |
title |
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). |
title_short |
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). |
title_full |
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). |
title_fullStr |
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). |
title_full_unstemmed |
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). |
title_sort |
targeting human microrna genes using engineered tal-effector nucleases (talens). |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease. |
url |
http://europepmc.org/articles/PMC3646762?pdf=render |
work_keys_str_mv |
AT ruozhenhu targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens AT jaredwallace targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens AT timothyjdahlem targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens AT davidjonahgrunwald targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens AT ryanmoconnell targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens |
_version_ |
1725027300519444480 |